Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CTXR · as of Jun 9, 2026
Key Statistics
Explore Citius Pharmaceuticals, Inc. Data
ctxr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 83.3%
Competitors & Peers
ctxr competitorsCTXR
ADTX
APLM
ATHA
CRIS
DAREStock Performance
Full HistoryAbout Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed tow…
what is citius pharmaceuticals, inc. · ctxr stock overview · citius pharmaceuticals, inc. company profile · who is citius pharmaceuticals, inc. ceo · ctxr NASDAQ · citius pharmaceuticals, inc. headquarters · citius pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Citius Pharmaceuticals, Inc. (CTXR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 2, 2014. As of the latest trading session, CTXR stock price is $0.59, with a market capitalization of $6.6M. The stock has returned -56.99% over the past 12 months and -24.17% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Citius Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Citius Pharmaceuticals, Inc. reported revenue of — and net income of -$37.4M. For detailed data — including Citius Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Citius Pharmaceuticals, Inc. (CTXR) stock price is $0.59. The stock is traded on NASDAQ under the ticker symbol CTXR. The 52-week range is $0.48 – $2.48.